fullscreen

eFinder

eFinder

Home › Medical Breakthroughs in Cancer Treatment › Article

Trial finds a new pill extends survival for people with pancreatic cancer | The Jerusalem Post

Jpost · · 292 words · By JERUSALEM POST STAFF
Medical Breakthroughs in Cancer Treatment
headphones Listen to the eFinder podcast briefing
Generate a natural audio summary of this story
Daily briefing

What to know about Medical Breakthroughs in Cancer Treatment

An experimental pill from company Revolution Medicines delivered a striking survival advantage for people with previously treated pancreatic cancer patients.

Claims checked 12
Techniques found 1
Topics 1

Coverage spectrum

Coverage gap: Low Left coverage
Left0%
Center83%
Right17%

6 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

An experimental pill from company Revolution Medicines delivered a striking survival advantage for people with previously treated pancreatic cancer patients.

Why it matters

The oral drug daraxonrasib doubled median overall survival versus standard intravenous cytotoxic chemotherapy.

Common ground

Patients on daraxonrasib lived a median 13.2 months compared with 6.7 months on chemotherapy.

Perspective signals

The tension in the story is sharpened by Glittering Generalities: language that can make the dispute feel more urgent, personal, or adversarial than the underlying facts alone.

open_in_new Read the original article: https://www.jpost.com/science/article-893588

psychologyPropaganda Techniques Detected

eFinder identified 1 propaganda technique in this article. These signals explain how wording, emphasis, or missing context can shape a reader's interpretation.

warning
Glittering Generalities 60% confidence
Using vague, emotionally appealing phrases ('freedom', 'justice') without specifics.
Found in this article: eFinder flagged this technique because the story's framing or source language may guide readers toward a particular interpretation. Review the claim checks and evidence below to separate what is directly supported from what is implied by wording or emphasis.
Why it matters: Recognizing glittering generalities helps readers compare the article's framing with the underlying facts and with coverage from other sources.

fact_checkClaims Checked

eFinder analyzed this article and checked 12 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

check_circle Corroborated 6
info Single Source 4
schedule Pending 2
schedule
Claim 1: “The vaccine has been associated with an average of 15 months without disease recurrence and a median overall survival of 29 months in pancreatic and colorectal cancer.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
check_circle
Claim 2: “Patients on daraxonrasib lived a median 13.2 months compared with 6.7 months on chemotherapy.”
CORROBORATED
The claim is corroborated by a cross-reference source and multiple web search results, all citing the specific median survival figures: 13.2 months for daraxonrasib versus 6.7 months for chemotherapy.
menu_book
wikipedia NEUTRAL — Media (Old Persian: 𐎶𐎠𐎭 Māda; Greek: Μηδία Mēdía; Akkadian: Mādāya) was a political entity centered in Ecbatana that existed from the 7th century BCE until the mid-6th century BCE and is believed to h…
https://en.wikipedia.org/wiki/Median_kingdom
menu_book
wikipedia NEUTRAL — The median of a set of numbers is the value separating the higher half from the lower half of a data sample, a population, or a probability distribution. For a data set, it may be thought of as the “m…
https://en.wikipedia.org/wiki/Median
menu_book
wikipedia NEUTRAL — The median income is the income amount that divides a population into two groups, half having an income above that amount, and half having an income below that amount. The median can be calculated for…
https://en.wikipedia.org/wiki/Median_income
+ 4 more evidence sources
schedule
Claim 3: “Researchers said the drug works by reprogramming the tumor microenvironment so the immune system can better attack the tumor.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
info
Claim 4: “A new drug developoed in Northwestern University improved outcomes when added to standard chemotherapy in trials spanning over 200 patients.”
SINGLE SOURCE
The evidence provided lists general information about Northwestern University and its facilities (Wikipedia), but none of the retrieved web search results or cross-references contain the specific claim that 'A drug developed at Northwestern University improved outcomes when added to standard chemotherapy in trials of over 200 patients.' The evidence is not specific enough to corroborate this claim.
menu_book
wikipedia NEUTRAL — Lanny and Sharon Martin Stadium (currently known as Northwestern Medicine Field at Martin Stadium for sponsorship reasons) is an outdoor sports and recreation facility on the campus of Northwestern Un…
https://en.wikipedia.org/wiki/Martin_Stadium_(Northwestern_U…
menu_book
wikipedia NEUTRAL — Northwestern University (NU) is a private research university in Evanston, Illinois, United States. Established in 1851, it is the oldest chartered university in Illinois. Northwestern was initially a…
https://en.wikipedia.org/wiki/Northwestern_University
menu_book
wikipedia NEUTRAL — The Northwestern University Lakefill (formally known as the James Roscoe Miller Campus) is a large area of Northwestern University land that was reclaimed from Lake Michigan in 1962–1964 by creating a…
https://en.wikipedia.org/wiki/Northwestern_University_Lakefi…
+ 3 more evidence sources
info
Claim 5: “About 13% of patients receiving the drug elraglusib were alive at two years compared with none in the control group, and the regimen was generally well-tolerated with a manageable safety profile.”
SINGLE SOURCE
The web search results provide the specific data points (13% alive at two years vs. none in control, and manageable regimen), but there are no cross-references or other independent sources to corroborate these findings.
menu_book
wikipedia NEUTRAL — There's Something About Mary is a 1998 American romantic comedy film directed by the Farrelly brothers, who co-wrote the screenplay with Ed Decter and John J. Strauss. The film features Cameron Diaz a…
https://en.wikipedia.org/wiki/There's_Something_About_Mary
menu_book
wikipedia NEUTRAL — About may refer to: About (surname) About.com, an online source for original information and advice about.me, a personal web hosting service About URI scheme, an internal URI scheme About box, a dial…
https://en.wikipedia.org/wiki/About
menu_book
wikipedia NEUTRAL — About us may refer to: About Us (novel), 1967 a novel by Chester Aaron "About Us" (song), a 2007 song by Brooke Hogan About Us (album), a 2019 album by Australian pop singer, G Flip About Us (film), …
https://en.wikipedia.org/wiki/About_us
check_circle
Claim 6: “Median survival reached 10.1 months versus 7.2 months for chemotherapy alone.”
CORROBORATED
Two independent web search results report the specific median survival figures: 10.1 months with elraglusib versus 7.2 months with chemotherapy alone.
menu_book
wikipedia NEUTRAL — The median of a set of numbers is the value separating the higher half from the lower half of a data sample, a population, or a probability distribution. For a data set, it may be thought of as the “m…
https://en.wikipedia.org/wiki/Median
menu_book
wikipedia NEUTRAL — The median income is the income amount that divides a population into two groups, half having an income above that amount, and half having an income below that amount. The median can be calculated for…
https://en.wikipedia.org/wiki/Median_income
menu_book
wikipedia NEUTRAL — Media (Old Persian: 𐎶𐎠𐎭 Māda; Greek: Μηδία Mēdía; Akkadian: Mādāya) was a political entity centered in Ecbatana that existed from the 7th century BCE until the mid-6th century BCE and is believed to h…
https://en.wikipedia.org/wiki/Median_kingdom
+ 3 more evidence sources
info
Claim 7: “The success of the Phase 3 study reverberated beyond the clinic, sending the company’s shares up more than a third in a single day.”
SINGLE SOURCE
While the web search results discuss clinical trials and drug development, none of the provided evidence sources mention the company's stock price movement or any specific percentage increase in shares following a Phase 3 study.
travel_explore
web search NEUTRAL — Single ascending dose (Phase Ia): In single ascending dose studies, small groups of subjects are given a single dose of the drug while they are observed and tested for a period of time to confirm safe…
https://en.wikipedia.org/wiki/Phases_of_clinical_research
travel_explore
web search NEUTRAL — Polyphor today announced the enrollment of the first patient in its PRISM-MDR European Phase III clinical trial for murepavadin (POL7080) for the treatment of ventilator-associated bacterial pneumonia…
https://www.linkedin.com/pulse/polyphor-announces-enrollment…
travel_explore
web search NEUTRAL — Download a free audiobook version of "The Richest Man in Babylon" and support TED-Ed's nonprofit mission: https://www.audible.com/ted-edCheck out our full bo...
https://www.youtube.com/watch?v=p7HKvqRI_Bo
check_circle
Claim 8: “The oral drug daraxonrasib doubled median overall survival versus standard intravenous cytotoxic chemotherapy.”
CORROBORATED
Multiple web search results state that daraxonrasib nearly doubled the overall survival compared to standard intravenous chemotherapy for previously treated metastatic pancreatic cancer.
travel_explore
web search NEUTRAL — Revolution Medicines announced Monday that its oral anticancer drug daraxonrasib almost doubled overall survival for patients with previously treated metastatic pancreatic cancer compared to standard …
https://en.walaw.press/articles/revolution_medicines_drug_ne…
travel_explore
web search NEUTRAL — Patients who received the once-daily pill, daraxonrasib, showed a median overall survival of 13.2 months compared with 6.7 months for those who were given intravenous cytotoxic chemotherapy, the stand…
https://www.france24.com/en/video/20260415-experimental-panc…
travel_explore
web search NEUTRAL — Treatment with daraxonrasib led to PFS and OS benefits vs SOC cytotoxic chemotherapy in patients with metastatic pancreatic ductal adenocarcinoma.
https://www.onclive.com/view/daraxonrasib-yields-significant…
check_circle
Claim 9: “The side-effect profile was manageable and includes rash.”
CORROBORATED
Multiple web search results confirm that the side-effect profile of daraxonrasib is manageable and specifically list rash as a common adverse event.
travel_explore
web search NEUTRAL — Safety and Tolerability Across dose-escalation cohorts, Daraxonrasib demonstrated a manageable and consistent safety profile. The most common treatment-related adverse events included rash, mucositis …
https://oncodaily.com/drugs/daraxonrasib
travel_explore
web search NEUTRAL — The multi-selective, tricomplex RAS (ON) inhibitor daraxonrasib (RMC-6236) yielded clinical activity and displayed a manageable safety profile in patients with previously treated non-small cell ...
https://www.onclive.com/view/daraxonrasib-generates-clinical…
travel_explore
web search NEUTRAL — Conclusions Daraxonrasib (120-220 mg daily) demonstrated encouraging and durable clinical activity in patients with NSCLC with a manageable safety and tolerability profile and favorable dose intensity…
https://www.jto.org/article/S1556-0864(25)00201-1/fulltext
check_circle
Claim 10: “Daraxonrasib was generally well-tolerated, with no new safety concerns identified.”
CORROBORATED
Multiple web search results state that daraxonrasib was generally well tolerated and that no new safety signals were identified.
travel_explore
web search NEUTRAL — Daraxonrasib was generally well tolerated, with a manageable safety profile and with no new safety signals. Based on the results from this first interim analysis, all PFS and OS endpoint results are c…
https://ir.revmed.com/news-releases/news-release-details/dar…
travel_explore
web search NEUTRAL — The trial also demonstrated statistically significant gains in PFS. Regarding safety, treatment with daraxonrasib was generally well tolerated, with no new safety signals and a manageable safety profi…
https://www.cancernetwork.com/view/daraxonrasib-shows-unprec…
travel_explore
web search NEUTRAL — In the overall (intent-to-treat) study population, daraxonrasib demonstrated a median OS of 13.2 months versus 6.7 months for chemotherapy, with a hazard ratio of 0.40 (p < 0.0001). Daraxonrasib was g…
https://www.biospace.com/press-releases/daraxonrasib-demonst…
check_circle
Claim 11: “An experimental pill from company Revolution Medicines delivered a striking survival advantage for people with previously treated pancreatic cancer patients.”
CORROBORATED
Multiple web search results report that Revolution Medicines' experimental drug, daraxonrasib, provided a survival advantage for previously treated pancreatic cancer patients.
travel_explore
web search NEUTRAL — April 13 () - Revolution Medicines' experimental oral drug helped patients with pancreatic cancer live longer and showed an improvement in survival without worsening of the disease in a keenly anticip…
https://finance.yahoo.com/sectors/healthcare/articles/revolu…
travel_explore
web search NEUTRAL — Revolution Medicines' experimental cancer pill boosts survival in late-stage study. 5 days ago. By Sriparna Roy.New pancreatic cancer drug nearly doubles survival time in patients.
https://news.google.com/stories/CAAqNggKIjBDQklTSGpvSmMzUnZj…
travel_explore
web search NEUTRAL — CALIFORNIA: Revolution Medicines said on April 13 that its experimental pancreatic cancer drug daraxonrasib significantly extended survival in a pivotal late-stage trial, marking one of the strongest …
https://californiamessenger.com/revolution-drug-pancreatic-c…
info
Claim 12: “The one-year survival rate doubled to roughly 44% from 22%, and the risk of death fell by 38%.”
SINGLE SOURCE
The web search results contain the specific statistics (one-year survival rate doubling to 44% from 22%, and risk of death falling by 38%), but the evidence count shows 0 cross-references and the web search results are not sufficient to establish corroboration from multiple independent news organizations.
menu_book
wikipedia NEUTRAL — The president of the United States is the head of state and head of government of the United States, indirectly elected to a four-year term via the Electoral College. Under the U.S. Constitution, the …
https://en.wikipedia.org/wiki/List_of_presidents_of_the_Unit…
menu_book
wikipedia NEUTRAL — The is a grammatical article in English, denoting nouns that are already or about to be mentioned, under discussion, implied or otherwise presumed familiar to listeners, readers, or speakers. It is th…
https://en.wikipedia.org/wiki/The
menu_book
wikipedia NEUTRAL — The is the definite article in English. The, or THE, may also refer to:
https://en.wikipedia.org/wiki/The_(disambiguation)
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.